Gotowe bibliografie tematyczne / Gene-targeted therapy

Spis treści

  1. Artykuły w czasopismach
  2. Rozprawy doktorskie
  3. Książki
  4. Części książek
  5. Streszczenia konferencji
  6. Raporty organizacyjne

Gotowa bibliografia na temat „Gene-targeted therapy”

Autor: Grafiati
Data publikacji: 2 czerwca 2025
Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Gene-targeted therapy”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Gene-targeted therapy"

1

Hart, I. R., and R. G. Vile. "Targeted gene therapy." British Medical Bulletin 51, no. 3 (1995): 647–55. http://dx.doi.org/10.1093/oxfordjournals.bmb.a072984.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Katz, Stephen I. "Prospects for targeted gene therapy." Clinical and Experimental Dermatology 25, no. 2 (2000): 157. http://dx.doi.org/10.1046/j.1365-2230.2000.0604c.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Miller, Nicholas, and Richard Vile. "Targeted vectors for gene therapy." FASEB Journal 9, no. 2 (1995): 190–99. http://dx.doi.org/10.1096/fasebj.9.2.7781922.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Harris, Jonathan D., and Nick R. Lemoine. "Strategies for targeted gene therapy." Trends in Genetics 12, no. 10 (1996): 400–405. http://dx.doi.org/10.1016/0168-9525(96)40031-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Dougherty, Graeme J., Peter D. Davis, and Shona T. Dougherty. "Vascular-targeted cancer gene therapy." Expert Opinion on Biological Therapy 4, no. 12 (2004): 1911–20. http://dx.doi.org/10.1517/14712598.4.12.1911.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Węgrzyn, Alicja. "Gene expression-targeted isoflavone therapy." IUBMB Life 64, no. 4 (2012): 307–15. http://dx.doi.org/10.1002/iub.1007.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Parekh-Olmedo, H., L. Ferrara, E. Brachman, and E. B. Kmiec. "Gene therapy progress and prospects: targeted gene repair." Gene Therapy 12, no. 8 (2005): 639–46. http://dx.doi.org/10.1038/sj.gt.3302511.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Rots, M. G., D. T. Curiel, W. R. Gerritsen, and H. J. Haisma. "Targeted cancer gene therapy: the flexibility of adenoviral gene therapy vectors." Journal of Controlled Release 87, no. 1-3 (2003): 159–65. http://dx.doi.org/10.1016/s0168-3659(02)00360-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

KONISHI, Hiroyasu, and Tetsuichiro MUTO. "Targeted Gene Therapy for Colorectal Cancer." Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) 24, no. 1 (1999): 1–7. http://dx.doi.org/10.4030/jjcs1979.24.1_1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Rocconi, Rodney, T. Numnum, Mariam Stoff-Khalili, Sharmila Makhija, Ronald Alvarez, and David Curiel. "Targeted Gene Therapy for Ovarian Cancer." Current Gene Therapy 5, no. 6 (2005): 643–53. http://dx.doi.org/10.2174/156652305774964668.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Gene-targeted therapy"

1

Harris, Jonathan David. "Targeted gene therapy for cancer." Thesis, Imperial College London, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.309239.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Samani, Amir Abbas. "IGF-IR targeted cancer gene therapy." Thesis, McGill University, 2004. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=18206.

Pełny tekst źródła
Streszczenie:
Since the declaration of “War on cancer” in 1971, and with the insight provided by recent advances in human genetics and in molecular technology , the field of cancer biology has been expanded rapidly providing hope that a cure for this lethal disease will be found. One of the major contributions of the field of cell biology to the understanding of malignant diseases has been the identification of growth factors and their receptors as major promoters of transformation and malignant progression. In particular, the appreciation of the central role that receptor tyrosine kinases (RTK) play in d
Style APA, Harvard, Vancouver, ISO itp.
3

Mckiver, Bryan D. "SND1-Targeted Gene Therapy for Hepatocellular Carcinoma." VCU Scholars Compass, 2018. https://scholarscompass.vcu.edu/etd/5676.

Pełny tekst źródła
Streszczenie:
Staphylococcal nuclease and tudor-domain containing 1 (SND1) is an oncogene for a wide variety of cancers, including hepatocellular carcinoma (HCC). SND1 is a multifunctional protein regulating gene expression of proto-oncogenes and tumor suppressor genes, making SND1 a prime target for developing cancer therapeutics. This notion is especially attributed to HCC as most patients are diagnosed in advanced stages and the therapeutic options available for these patients are severely limited. In this study, we evaluated the therapeutic potential of a replication-defective adenovirus vector deliveri
Style APA, Harvard, Vancouver, ISO itp.
4

Sabine, Victoria Saranne. "Targeted gene therapy for canine osteosarcoma : preliminary investigations." Thesis, University of Glasgow, 2010. http://theses.gla.ac.uk/1642/.

Pełny tekst źródła
Streszczenie:
Osteosarcoma (OS) is the most common bone cancer in dogs. It is biologically aggressive and <20% survive >2 years with standard therapy. Hence, new approaches must be considered. TP53 is altered in ~50% of human and canine cancers, including OS, making it a candidate for targeted suicide gene therapy strategies. Canine OS is considered to be a good model for human OS. The aims of this study were to:  examine the site incidence of canine OS retrieved from Glasgow University Veterinary School (GUVS) histology database;  perform TP53 mutational analysis in canine OS cases diagnosed at GUVS;  i
Style APA, Harvard, Vancouver, ISO itp.
5

Shaw, James Alistair MacGregor. "Towards muscle-targeted gene therapy for diabetes mellitus." Thesis, University of Aberdeen, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.325232.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Diaz, Marcano Rosa Maria. "Viral vectors for targeted gene therapy of cancer." Thesis, King's College London (University of London), 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.267735.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Monfort, Dagmara Anne. "Recombinant Elastin Based Nanoparticles for Targeted Gene Therapy." Scholar Commons, 2017. http://scholarcommons.usf.edu/etd/6627.

Pełny tekst źródła
Streszczenie:
Gene therapy is a technique used to inactivate, replace or insert a corrective copy of a defective gene in order to help diseased tissues to function properly. Gene therapy is a promising treatment for many diseases cancer, cystic fibrosis, and Parkinson’s. There are different methods to introduce a gene to the cell; one of them is the use of viruses. Among viruses, lentiviruses have been popular vectors for gene delivery due to their efficient mode of gene delivery. However, the non-specific delivery of genes associated with viruses may result in undesirable side effects. Here, we propose a h
Style APA, Harvard, Vancouver, ISO itp.
8

Taylor, Sarah Louise. "Development of an ultrasound-targeted retroviral gene therapy vector." Thesis, Institute of Cancer Research (University Of London), 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.436328.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Denby, Laura. "Development of targeted gene therapy vectors for cardiovascular disease." Thesis, University of Glasgow, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.422499.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Jackson, Laura. "Oxygen-regulated gene expression in Escherichia coli and hypoxia-targeted gene therapy." Thesis, University of Sheffield, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.414676.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Gene-targeted therapy"

1

Lao, Yeh-Hsing. Nanosystems for Gene Editing and Targeted Therapy. [publisher not identified], 2019.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Ward, Christopher Michael. Development of folate-targeted non-viral vectors for systemic cancer gene therapy. University of Birmingham, 2000.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Bo, Xuenong, and Joost Verhaagen. Gene delivery and therapy for neurological disorders. Humana Press, 2015.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Houghton, Peter J., and Robert Arceci. Molecularly targeted therapy for childhood cancer. Springer, 2010.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Slabý, Ondřej. MicroRNAs in solid cancer: From biomarkers to therapeutic targets. Nova Science, 2011.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Kahn, Michael. Targeting the Wnt pathway in cancer. Springer, 2011.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

N, Syrigos Konstantinos, and Harrington Kevin J. 1958-, eds. Targeted therapy for cancer. Oxford University Press, 2003.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Williams, Sophie I., and Christopher E. Rogers. HER2 and cancer: Mechanism, testing, and targeted therapy. Nova Biomedical Books, 2011.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

W, Siemann Dietmar, ed. Vascular-targeted therapies in oncology. J. Wiley, 2006.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Biotargets Of Cancer In Current Clinical Practice. Humana Press, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Gene-targeted therapy"

1

Hart, I. R. "Transcriptionally Targeted Gene Therapy." In Current Topics in Microbiology and Immunology. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-80071-9_2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Mohammad, Akheel, and Ashmi Wadhwania. "Targeted Therapy, Immunotherapy, and Gene Therapy." In Head and Neck Oncology. CRC Press, 2021. http://dx.doi.org/10.1201/9780367822019-23.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

R., Catherine, O’ Riordan, and Antonius Song. "PEGylated Adenovirus for Targeted Gene Therapy." In Gene Therapy Protocols. Humana Press, 2008. http://dx.doi.org/10.1007/978-1-60327-248-3_9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Wu, Hongju, and David T. Curiel. "Fiber-modified Adenoviruses for Targeted Gene Therapy." In Gene Therapy Protocols. Humana Press, 2008. http://dx.doi.org/10.1007/978-1-60327-248-3_8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Shen, Fanxia, and Hua Su. "Targeted Gene Therapy for Ischemic Stroke." In Neuromethods. Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-2306-9_8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

de Gruijl, Tanja D., Herbert M. Pinedo, and Rik J. Scheper. "Immunotherapy of Cancer by Dendritic Cell-Targeted Gene Transfer." In Cancer Gene Therapy. Humana Press, 2005. http://dx.doi.org/10.1007/978-1-59259-785-7_10.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Alsaggar, Mohammad, and Dexi Liu. "Liver-Targeted Gene and Cell Therapies: An Overview." In Gene Therapy and Cell Therapy Through the Liver. Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-55666-4_1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Dougherty, Graeme J., Peter D. Davis, and Shona T. Dougherty. "Development of Vasculature-targeted Cancer Gene Therapy." In Vascular-Targeted Therapies in Oncology. John Wiley & Sons, Ltd, 2006. http://dx.doi.org/10.1002/0470035439.ch14.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Jia, Li-Jun, and Zi-Chun Hua. "Development of Bacterial Vectors for Tumor-Targeted Gene Therapy." In Gene Therapy of Cancer. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-59745-561-9_7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Bilbao, G., J. Gómez-Navarro, and David T. Curiel. "Targeted Adenoviral Vectors for Cancer Gene Therapy." In Advances in Experimental Medicine and Biology. Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5357-1_57.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Gene-targeted therapy"

1

Kusumanchi, Praveen, Yonghua Zhang, Padma Chakka, et al. "Abstract 1506: Prodrug targeted gene therapy for colorectal cancer." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-1506.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Noble, Misty L., Shuxian Song, Ryan R. Sun, et al. "Improved luciferase gene expression using ultrasound targeted microbubble destruction therapy in swine." In 12TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2012. http://dx.doi.org/10.1063/1.4769917.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Rezzoug, Francine, Shelia D. Thomas, Segen Tella, and Donald M. Miller. "Abstract 1522: Targeted gene therapy · c-MYC and hTERT in the scope." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-1522.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Zhang, Fan, Miacheal E. Coon, Neha N. Parayath, Sirrka B. Stephan, Smitha P. Pillai, and Matthias T. Stephan. "Abstract 4770: Programming tumor-clearing macrophages with targeted in situ gene therapy." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-4770.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Zhang, Fan, Miacheal E. Coon, Neha N. Parayath, Sirrka B. Stephan, Smitha P. Pillai, and Matthias T. Stephan. "Abstract 4770: Programming tumor-clearing macrophages with targeted in situ gene therapy." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-4770.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Wilson, Ariel, Javier Mazzaferri, Éric Bergeron, et al. "In vivo laser targeted gene therapy of retina ganglion cells (Conference Presentation)." In Ophthalmic Technologies XXIX, edited by Fabrice Manns, Per G. Söderberg, and Arthur Ho. SPIE, 2019. http://dx.doi.org/10.1117/12.2509870.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Duong, Connie, Cathy Chen, Sakiko Yoshida, et al. "Abstract 5423: Novel targeted therapy for neuroblastoma: Silencing the MXD3 gene using siRNA." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-5423.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Little, Annette S., Jessica Hunt, David Hughes, et al. "Abstract A148: Modeling patient responses to targeted therapy with rAAV mediated gene editing." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-a148.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Phelps, Michael, Heechang Yang, and Eleanor Chen. "Abstract 5096: Targeted ablation of essential oncogenes in rhabdomyosarcoma with CRISPR/Cas9 gene therapy." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-5096.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Petrov, G. O., V. S. Mukhanov, and M. A. Dymova. "DEVELOPMENT M13 BACTERIOPHAGE-BASED TARGETED HYBRID VECTORS FOR HUMAN GLIOBLASTOMA CELL SELECTIVE TRANSDUCTION." In X Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов — 2023. Novosibirsk State University, 2023. http://dx.doi.org/10.25205/978-5-4437-1526-1-357.

Pełny tekst źródła
Streszczenie:
Bacteriophages, bacterial viruses, are currently being used as source of effective gene therapy tools for cancer. The aim of this study was to develop targeted hybrid vectors based on filamentous phage M13, capable of efficient and selective delivery of transgenes into U-87 MG human glioblastoma cells.
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Gene-targeted therapy"

1

Ponnazhagan, Selvarangan. Targeted Gene Therapy for Breast Cancer. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada427915.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Kasahara, Noriyuki. Viroreplicative Gene Therapy Targeted to Prostate Cancer. Defense Technical Information Center, 2010. http://dx.doi.org/10.21236/ada538598.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Von Seggern, Daniel J. Adenoviral Gene Therapy Vectors Targeted to Prostate Cancer. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada429389.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

VonSeggern, Daniel J. Adenoviral Gene Therapy Vectors Targeted to Prostate Cancer. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada417951.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Krasnykh, Victor. Derivation of Targeted Phage Vectors for Gene Therapy of Prostate Cancer. Defense Technical Information Center, 2006. http://dx.doi.org/10.21236/ada462846.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Krasnykh, Victor. Derivation of Double-Targeted Adenovirus Vectors for Gene Therapy of Prostate Cancer. Defense Technical Information Center, 2005. http://dx.doi.org/10.21236/ada439290.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Krasnykh, Victor. Derivation of Double-Targeted Adenovirus Vectors for Gene Therapy of Prostate Cancer. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada419820.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Hatefi, Arash. Development of a Nature-Inspired Vector for Targeted Systemic Breast Cancer Gene Therapy. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada493871.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Rogers, Buck E. Gene Therapy of Disseminated Breast Cancer Using Adenoviral Vectors Targeted Through Immunological Methods. Defense Technical Information Center, 1998. http://dx.doi.org/10.21236/adb244250.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Wei, Fang. Multifunctional Virus-Nanoshell Assembly for Targeted Hyperthermia and Viral Gene Therapy for Breast Cancer. Defense Technical Information Center, 2012. http://dx.doi.org/10.21236/ada566649.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Gene-targeted therapy” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii